```html

Keratoderma Climactericum

Overview

Keratoderma climactericum (also called acquired palmoplantar keratoderma of menopause) is a benign, acquired thickening of the skin on the palms and soles that typically appears around the time of the menopausal transition. Unlike inherited palmoplantar keratodermas, this condition is not present at birth and develops later in life, most often in women aged 45‑60 years. It is considered a manifestation of hormonal changes, particularly declining estrogen levels, although the exact pathophysiology remains incompletely understood.

The condition is relatively uncommon; epidemiologic data are limited, but case series from dermatology clinics suggest a prevalence of 0.5 %–1 % of post‑menopausal women who present with unexplained palmoplantar hyperkeratosis[^1]. Because it can be mistaken for other skin disorders (psoriasis, eczema, or genetic keratodermas), the true prevalence may be higher.

Symptoms

Patients with keratoderma climactericum usually notice a gradual change in the texture of the skin on their hands and feet. Common symptoms include:

• Symmetrical thickening of the palms and soles – often described as a “greasy” or “waxy” plaque that may be faintly yellowish.
• Rough, sandpaper‑like texture – can make gripping objects uncomfortable.
• Fissuring or cracking – especially on weight‑bearing areas of the soles; may be painful.
• Hyperhidrosis – excessive sweating that can worsen maceration and fissuring.
• Itching or mild burning sensation – usually not severe, but can be bothersome.
• Absence of inflamed plaques – unlike psoriasis, there is typically no erythema or scaling beyond the hyperkeratotic zone.
• Onset timing – symptoms appear within 1‑3 years of the final menstrual period in most cases.

Causes and Risk Factors

The exact cause is unknown, but several mechanisms have been proposed:

• Hormonal shift – Declining estrogen and relative increase in androgens alter keratinocyte turnover, leading to hyperkeratosis.
• Genetic predisposition – Some families report multiple affected members, suggesting a polygenic susceptibility.
• Environmental triggers – Occupational exposure to friction, repetitive hand‑foot trauma, or chronic moisture may exacerbate the condition.

Risk factors include:

• Female sex, especially post‑menopausal age (45‑65 y).
• Family history of palmoplantar keratoderma.
• Occupations requiring frequent manual labor or prolonged standing.
• Concurrent skin conditions that affect barrier function (e.g., atopic dermatitis).
• Smoking – may impair microcirculation and delay skin healing.

Diagnosis

Diagnosis is primarily clinical, based on history and physical examination. The dermatologist will look for the characteristic symmetric, non‑inflammatory hyperkeratosis of the palms and soles in a post‑menopausal woman.

Key diagnostic steps

1. Detailed history – timing relative to menopause, family history, occupational exposure, and prior skin disorders.
2. Physical examination – inspection of the palms/soles, assessment of thickness, fissuring, and presence/absence of erythema.
3. Dermatologic dermoscopy – may reveal yellowish lamellar scales without the vascular patterns typical of psoriasis.
4. Skin biopsy (optional) – if the presentation is atypical, a 4‑mm punch biopsy can show hyperkeratosis, acanthosis, and normal or mildly increased inflammatory cells, helping rule out other entities.
5. Laboratory tests (rule‑out) – basic blood work (CBC, fasting glucose, thyroid function) if there is suspicion of systemic disease causing secondary keratoderma.

According to the American Academy of Dermatology (AAD), a biopsy is unnecessary in classic cases, but it can be valuable when the differential includes psoriasis, eczema, or inherited keratodermas[^2].

Treatment Options

Because keratoderma climactericum is not life‑threatening, treatment focuses on symptom relief and improving skin appearance.

Topical Therapies

• Urea 10 %–40 % creams or gels – keratolytic, softens hyperkeratotic plaques; applied twice daily.
• Salicylic acid 2 %–6 % ointments – helps exfoliate thickened skin; may cause irritation, so start with low concentration.
• Retinoid creams (tazarotene 0.05 %) – promote normalized keratinocyte differentiation; monitor for dryness.
• Calcipotriene (vitamin D analog) – useful if there is an overlapping psoriasis‑like component.

Systemic Medications

• Oral retinoids (acitretin 25 mg daily) – effective for severe cases but require liver function monitoring and contraception (due to teratogenicity).
• Hormone replacement therapy (HRT) – limited data suggest that restoring estrogen may ameliorate symptoms; discuss risks/benefits with a physician.

Procedural Options

• Mechanical debridement – gentle filing or pumice stone use under dermatologic guidance to reduce plaque thickness.
• Laser therapy (CO₂ or Er:YAG) – selective ablation of hyperkeratotic layers; reserved for refractory cases.
• Phototherapy (PUVA) – rarely used, but can improve keratinization in some patients.

Lifestyle & Home Care

• Moisturize after each wash with an ointment containing ceramides or petrolatum.
• Avoid harsh detergents; use mild, fragrance‑free soaps.
• Wear cotton‑lined gloves and moisture‑wicking socks to reduce friction and hyperhidrosis.
• Regularly trim toenails and calluses to prevent secondary infection.
• Maintain optimal glycemic control if diabetic, as hyperglycemia worsens skin barrier dysfunction.

Living with Keratoderma Climactericum

While the condition is chronic, many patients achieve good control with a consistent skin‑care regimen.

Practical Tips

• Establish a twice‑daily moisturizing routine – apply ointment within 3 minutes of bathing to lock in moisture.
• Use protective padding – silicone pads or cushioned insoles can reduce pressure on the soles during walking.
• Schedule regular follow‑ups – at least every 6‑12 months to assess treatment efficacy and monitor for side effects of systemic drugs.
• Stay active safely – low‑impact exercises (swimming, cycling) avoid excessive foot trauma.
• Seek early treatment for fissures – cracked skin can become infected; use topical antibiotics if signs of infection appear.

Psychosocial Aspects

Visible changes to the hands can affect confidence. Consider joining a support group for women with menopausal skin changes or seeking counseling if anxiety or depression develops.

Prevention

Because hormonal changes are inevitable, primary prevention is limited. However, risk can be lowered by:

• Maintaining skin hydration throughout adulthood.
• Limiting chronic friction or pressure on palms/soles (e.g., ergonomic tools, cushioned footwear).
• Managing hyperhidrosis with antiperspirants (aluminum‑chloride) or topical glycopyrrolate.
• Discussing HRT options with a healthcare provider if menopausal symptoms are severe.

Complications

If left untreated, keratoderma climactericum can lead to:

• Deep fissuring – painful cracks that may bleed.
• Secondary bacterial or fungal infection – cellulitis, tinea pedis, or onychomycosis.
• Restricted mobility – severe plantar thickening can affect gait and increase fall risk.
• Psychological distress – due to cosmetic concerns or chronic discomfort.

When to Seek Emergency Care

---

Sources:

1. Mayo Clinic. “Palmoplantar keratoderma.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/palmoplantar-keratoderma
2. American Academy of Dermatology. “Diagnosis of palmoplantar keratoderma.” Clinical Guidelines, 2022.
3. National Institutes of Health, National Library of Medicine. “Acquired keratoderma of menopause.” MedlinePlus, 2021.
4. World Health Organization. “Menopause and skin health.” WHO Technical Report Series, 2020.
5. Cleveland Clinic. “Topical treatments for hyperkeratotic skin disorders.” Patient Education, 2024.

```